Recruiting

Observational Study

Sponsor:

Henry Ford Health System

Code:

NCT07769151

Conditions

Mortality Prediction

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

blood sample to check CXCL9 pre stem cell transplant and cell therapy

Study Details

Brief summary:

The purpose of this research is test if combination of physical tests and blood tests drawn before SCTCT can predict NRM.

Conditions

Mortality Prediction

Study ID

NCT07769151

Start date

Sep 1, 2026

Status verified date

Aug, 2026

Completion date

Dec 30, 2031

Anticipated

Primary completion date

Dec 30, 2030

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • patients >18 year old planned for SCTCT

Exclusion Criteria:

  • Pregnancy, prisoners , Patients with a serious medical or psychiatric illness likely to interfere with participation in this clinical study

Study Design

Enrollment

124 participants

Anticipated

Interventions and Outcome Measures

Interventions

blood sample to check CXCL9 pre stem cell transplant and cell therapy

Pre SCTCT as per SOC physical function assessment will be performed in a form of IADl, hand grip, and or walk test like TUG. Specimen Collection Studies: LDH , albumin, ferritin, CRP, platelet and creatinine will be collected as per standard of care pre SCTCT. The non-SOC procedure will be drawing CXL9

Primary outcome measure

  • Non relapse mortality (NRM) [ Time Frame: NRM at day 100 and at year 1 ]

Central Contacts and Locations

Central contacts

Locations

Henry Ford Health

Recruiting

Detroit, Michigan, United States, 48202

Contacts

More Information

Sponsor

Henry Ford Health System

Last update posted

Aug 17, 2026

Last verified

Aug, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Henry Ford Health System on 2026-08-17.